Acne is the most common skin disorder in the U.S
yet a cure remains elusive. Current treatments, including topical medications that decrease sebum or kill bacteria; oral medications such as birth control pills, antibiotics or isotretinoin; and lasers or light-based treatments, can offer temporary relief. But concerns about antibiotic resistance, combined with the serious risks—and associated regulations—of isotretinoin, are driving the development of new alternatives.
“Dermatologists are essentially using 40-year-old therapies to treat acne, but they are increasingly worried about the problem of antibiotic resistance, which the World Health Organization calls ‘one of the biggest threats to global health,’” says G. Scott Herron, MD, PhD, medical director of BioPharmX, developer of BPX-01, a topical minocycline gel formulation for the treatment of acne. Although there have been few advances in recent years, current research into new topical preparations and laser protocols has many hopeful.
Team Rejuvee